Vida Cannabis has announce that its wholly owned subsidiary Vida Cannabis (Canada) submitted its application to become a licensed commercial producer for its 300,000-plus-square-foot medical marijuana production facility in Stellarton, Nova Scotia under the Marihuana for Medical Purposes Regulations (MMPR).
Subscribe to our email newsletter
The 600-plus-page treatise was sent to Health Canada on 5 May 2014.
The conditions that must be met before the issuance of a licence are understandably extensive due to the potential public health, safety and security risks involved in the production and distribution of medical marijuana.
Health Canada requires potential producers to provide detailed measures related to security, good production practices, packaging, labelling and shipping, record keeping and reporting and distribution. In addition, all key personnel, directors and officers must hold a valid enhanced security clearance.
Vida Canada’s management, legal and consulting teams contributed an overwhelming amount of knowledge, expertise, time and effort in preparing the application package and reviewing the MMPR, other applicable legislation and policy guidelines to ensure the strictest compliance.
In line with Vida’s guiding principles, all plans were prepared to ensure that Vida Canada not only fulfills all the mandatory requirements, but surpasses the required standards whenever possible, as it aspires to have the best cultivation facility, security and operational systems in place.
Vida chairman and CEO Greg Wilson noted that the submission of its application package is a critical milestone in Vida Canada’s journey towards licensure.
"Moreover, I feel incredibly fortunate to have worked with the people I consider to be the best in the business in preparing our application," Wilson added.
In the application, Vida Canada enumerated the activities it wishes to conduct with marijuana and the purpose for conducting those activities.